196:
temperature measurement. From March 2016 to March 2020 a clinical study was conducted to determine the atypical core body temperature patterns and implications for conditions related to pregnancy, infertility and miscarriage risk. The study concluded that the atypical core body temperature patterns may aid diagnosis especially in elevated risk of miscarriage and pregnancy issues. A similar study was conducted in 2016 which determined the atypical vaginal temperature patterns and how it can show subtle, but not yet recognized, causes of infertility. From March 2016 to
December 2019 a clinical study was conducted to see how the atypical temperature patterns can aid to identify infertility issues and miscarriage risks. The study proved that the atypical core body temperature patterns can aid in a diagnosis especially in an elevated risk of miscarriage.
144:
187:
app which then analyzes and produces an accurate daily fertility graph. OvuSense measures core body temperature because it has been proven to be more reliable than testing urine and measuring the external body temperature. The app also includes medication or supplement tracking to see how they effect cycle patterns as well as a feature to determine opportunities of increased fertility.
186:
The technology to make OvuSense was founded by Dr. Andy
Butterworth and Professor Toby Knowles at the University of Bristol. OvuSense is an app that measures the core body temperature via a sensor worn in the vagina overnight. In the morning, the user downloads data from the sensor to the OvuSense
195:
Several clinical trials were conducted to better test the effectiveness of OvuSense. In
September 2012 a clinical trial was conducted to assess the vaginal temperature in comparison to an oral temperature measurement. The clinical trial showed that the OvuSense was more reliable over the oral
212:
122:
110:
126:
106:
118:
262:
336:
238:
164:
93:
86:
50:
37:
75:
26:
160:
288:
170:
213:"Women Are Taking Back Control With OvuSense, A Game Changing Combined Sensor And Fertility App"
8:
82:
61:
33:
114:
97:
54:
156:
21:
312:
239:"Ground-breaking fertility sensor and app developed by Bristol scientists"
190:
289:"August: fertility sensor | News and features | University of Bristol"
263:"Fertility Focus fundraises $ 2.7M to commercialize OvuSense platform"
181:
199:
66:
64:
to this revision, which may differ significantly from the
313:"OvuSense Reviews - Medical Info & Community Reviews"
74:Revision as of 09:27, 17 September 2024 by
47:
73:
14:
44:
25:
137:
17:
286:
236:
135:
104:
337:"OvuSense Ovulation Detection Kit"
136:
362:
60:. The present address (URL) is a
142:
94:User:Thekz Cos/sandbox/Ovusense
51:User:Thekz Cos/sandbox/Ovusense
329:
305:
280:
255:
230:
205:
169:Please discuss further on the
13:
1:
7:
159:to comply with Knowledge's
24:of this page, as edited by
10:
367:
287:Bristol, University of.
237:Bristol, University of.
45:09:27, 17 September 2024
151:This article contains
92:(Thekz Cos moved page
49:(Thekz Cos moved page
165:neutral point of view
153:paid contributions.
111:← Previous revision
98:Knowledge:OvuSense
55:Knowledge:OvuSense
293:www.bristol.ac.uk
243:medicalxpress.com
179:
178:
358:
351:
350:
348:
347:
333:
327:
326:
324:
323:
309:
303:
302:
300:
299:
284:
278:
277:
275:
274:
259:
253:
252:
250:
249:
234:
228:
227:
225:
224:
209:
174:
161:content policies
146:
145:
138:
123:Newer revision →
101:
90:
69:
67:current revision
59:
58:
46:
42:
41:
366:
365:
361:
360:
359:
357:
356:
355:
354:
345:
343:
335:
334:
330:
321:
319:
311:
310:
306:
297:
295:
285:
281:
272:
270:
261:
260:
256:
247:
245:
235:
231:
222:
220:
211:
210:
206:
202:
193:
191:Clinical trials
184:
175:
168:
163:, particularly
155:It may require
147:
143:
134:
133:
132:
131:
130:
115:Latest revision
103:
102:
91:
80:
78:
65:
48:
31:
29:
12:
11:
5:
364:
353:
352:
328:
317:thelowdown.com
304:
279:
267:MobiHealthNews
254:
229:
203:
201:
198:
192:
189:
183:
180:
177:
176:
150:
148:
141:
76:
62:permanent link
27:
16:
15:
9:
6:
4:
3:
2:
363:
342:
338:
332:
318:
314:
308:
294:
290:
283:
268:
264:
258:
244:
240:
233:
218:
214:
208:
204:
197:
188:
172:
166:
162:
158:
154:
149:
140:
139:
128:
124:
120:
116:
112:
108:
99:
95:
88:
84:
79:
72:
71:
68:
63:
56:
52:
39:
35:
30:
23:
344:. Retrieved
341:Nabta Health
340:
331:
320:. Retrieved
316:
307:
296:. Retrieved
292:
282:
271:. Retrieved
269:. 2019-01-28
266:
257:
246:. Retrieved
242:
232:
221:. Retrieved
219:. 2016-07-25
216:
207:
194:
185:
152:
22:old revision
19:
18:
182:Application
20:This is an
346:2024-09-17
322:2024-09-17
298:2024-09-17
273:2024-09-17
248:2024-09-17
223:2024-09-17
200:References
171:talk page
77:Thekz Cos
28:Thekz Cos
217:BioSpace
87:contribs
38:contribs
157:cleanup
127:diff
121:) |
119:diff
107:diff
83:talk
34:talk
96:to
53:to
43:at
339:.
315:.
291:.
265:.
241:.
215:.
113:|
109:)
85:|
36:|
349:.
325:.
301:.
276:.
251:.
226:.
173:.
167:.
129:)
125:(
117:(
105:(
100:)
89:)
81:(
70:.
57:)
40:)
32:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.